Gyre Therapeutics (GYRE) News Today → There’s only one solution to the impending energy catastrophe… (From DTI) (Ad) Free gyre Stock Alerts $11.04 0.00 (0.00%) (As of 06/14/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 16 at 2:20 AM | americanbankingnews.comGyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $11.04June 7, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.76Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.76June 7, 2024 | americanbankingnews.comGyre Therapeutics (NASDAQ:GYRE) Trading Down 3%June 5, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Shares Down 3% Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3%June 3, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Shares Gap Down to $11.36Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down to $11.36May 30, 2024 | globenewswire.comGyre Pharmaceuticals Receives IND Approval from China's NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial HypertensionMay 30, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Trading 5.1% Higher Gyre Therapeutics (NASDAQ:GYRE) Trading 5.1% HigherMay 28, 2024 | globenewswire.comGyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® IndexesMay 12, 2024 | seekingalpha.comGyre Therapeutics GAAP EPS of $0.03, revenue of $27.17MMay 11, 2024 | finance.yahoo.comGyre Therapeutics Reports First Quarter 2024 EarningsMay 10, 2024 | finanznachrichten.deGyre Therapeutics, Inc.: Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 10, 2024 | msn.comGYRE Stock Earnings: Gyre Therapeutics Reported Results for Q1 2024May 9, 2024 | globenewswire.comGyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 4, 2024 | insidertrades.comNassim Usman Sells 20,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) StockApril 27, 2024 | finance.yahoo.comPublic companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last weekApril 17, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.1%Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.1%April 13, 2024 | seekingalpha.comGyre Therapeutics: Under The Radar Biotech Has A Shot At MASH Approval, In TimeApril 10, 2024 | marketbeat.comGyre Therapeutics (NASDAQ:GYRE) Shares Down 9.8% Gyre Therapeutics (NASDAQ:GYRE) Trading Down 9.8%April 5, 2024 | investing.comGyre therapeutics director Nassim Usman sells shares worth $323,000March 26, 2024 | markets.businessinsider.comGyre Therapeutics Posts Loss In 2023March 26, 2024 | globenewswire.comGyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateMarch 26, 2024 | seekingalpha.comRNAZ TransCode Therapeutics, Inc.March 21, 2024 | globenewswire.comGyre Therapeutics Expands Board of Directors with Appointment of Rodney L. NussbaumMarch 12, 2024 | finance.yahoo.comGyre Therapeutics, Inc. (GYRE) stock forecast and price targetFebruary 28, 2024 | seekingalpha.comTVTX Travere Therapeutics, Inc.February 22, 2024 | msn.comCantor Fitzgerald Downgrades RAPT Therapeutics (RAPT)December 21, 2023 | morningstar.comGyre Therapeutics IncDecember 15, 2023 | marketwatch.comGyre Therapeutics Names Han Ying As CEODecember 15, 2023 | finance.yahoo.comTotus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B FundingDecember 2, 2023 | seekingalpha.comGYRENovember 16, 2023 | morningstar.comGyre Therapeutics Inc GYRENovember 13, 2023 | finance.yahoo.comGyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver MeetingNovember 10, 2023 | barrons.comGyre Therapeutics Inc.November 9, 2023 | finance.yahoo.comGyre Therapeutics, Inc. (GYRE) Get Gyre Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GYRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy these “two-bagger” stocks (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable. Download your free report today! GYRE Media Mentions By Week GYRE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GYRE News Sentiment▼0.640.91▲Average Medical News Sentiment GYRE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GYRE Articles This Week▼31▲GYRE Articles Average Week Get Gyre Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GYRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Axsome Therapeutics News Today Corcept Therapeutics News Today Merus News Today Prestige Consumer Healthcare News Today Arrowhead Pharmaceuticals News Today Amicus Therapeutics News Today HUTCHMED News Today Geron News Today IDEAYA Biosciences News Today Biohaven News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GYRE) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored